Kushima H, Tokimatsu I, Ishii H,et al. Cloning of the lanosterol 14-alpha-demethylase (ERG11) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in ？T. asahii？[J]. FEMS Yeast Res, 2012, 12(6): 662-667. [2]Kinsman O S, Collard A E. Hormonal factors in vaginal candidiasis in rats[J]. Infect Immun, 1986, 53(3): 498-504. [3]Zhang X, Essmann M, Burt E T,et al. Estrogen effects on Candida albicans: a potential virulence-regulating mechanism[J]. J Infect Dis, 2000, 181(4): 1441-1446. [4]Zhang X, De-Micheli M, Coleman S T,et al. Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p[J]. Mol Microbiol, 2000, 36(3): 618-629. [5]Fidel P L Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis[J]. Infect Immunity. 2000, 68(2): 651-657. [6]Madani N D, Malloy P J, Rodriguez-Pombo P,et al. Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol[J]. Proc Natl Acad Sci U S A, 1994, 91(3): 922-926. [7]Cheng G, Yeater K M, Hoyer L L. Cellular and molecular biology of Candida albicans estrogen response[J]. Eukaryot Cell, 2006, 5(1): 180-191. [8]Banerjee D, Martin N, Nandi S,et al. A genome-wide steroid response study of the major human fungal pathogen Candida albicans[J]. Mycopathologia, 2007, 164(1): 1-17. [9]Banerjee D, Pillai B, Karnani N,et al. Genome-wide expression profile of steroid response in Saccharomyces cerevisiae[J]. Biochem Biophys Res Commun, 2004, 317(2): 406-413. [10]Banerjee D, Lelandais G, Shukla S,et al. Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks[J]. Eukaryot Cell, 2008, 7(1): 68-77. [11]Tanaka S, Hasegawa S, Hishinuma F,et al. Estrogen can regulate the cell cycle in the early G1 phase of yeast by increasing the amount of adenylate cyclase mRNA[J]. Cell, 1989, 57(4): 675-681. [12]Romani L, Bistoni F, Puccetti P. Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts[J]. Curr Opin Microbiol, 2003, 6(4): 338-343. [13]Manoharlal R, Sharma M, Prasad R. Molecular determinants of transient and reversible induced up-regulation of CaCDR1 in azole susceptible clinical isolates of Candida albicans[J]. Biosci Rep, 2011, 31(1): 31-43. [14]Krishnamurthy S, Chatterjee U, Gupta V,et al. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system[J]. Yeast. 1998, 14(6): 535-550. [15]Karnani N, Gaur N A, Jha S,et al. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter[J]. Yeast, 2004, 21(3): 219-239. [16]de-Micheli M, Bille J, Schueller C,et al. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance[J]. Mol Microbiol, 2002, 43(5): 1197-1214. ？
